← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

IMAC Holdings, Inc. (BACK) 10-Year Financial Performance & Capital Metrics

BACK • • Industrial / General
HealthcareHealthcare FacilitiesRehabilitation & Therapy ServicesOutpatient Therapy Clinics
AboutIMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.Show more
  • Revenue $72K -98.6%
  • EBITDA -$5M -116.1%
  • Net Income -$9M +4.0%
  • EPS (Diluted) -7.76 -5.4%
  • Gross Margin -323.66% -537.1%
  • EBITDA Margin -7611.5% -15485.7%
  • Operating Margin -7804.67% -13688.6%
  • Net Margin -12554.93% -6827.6%
  • ROE -
  • ROIC -
  • Debt/Equity -
  • Interest Coverage -8.29 +64.8%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 94 (top 6%)

✗Weaknesses

  • ✗Weak Piotroski F-Score: 1/9
  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Sales declining 65.7% over 5 years
  • ✗Shares diluted 41.2% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-65.68%
3Y-82.89%
TTM100.46%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-77.89%

EPS CAGR

10Y-
5Y-
3Y-
TTM-42.31%

ROCE

10Y Avg-97.59%
5Y Avg-76.71%
3Y Avg-102.63%
Latest-

Peer Comparison

Outpatient Therapy Clinics
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
USPHU.S. Physical Therapy, Inc.1.33B87.7047.6611%5.05%4.27%4.93%0.39
BACKIMAC Holdings, Inc.461.77K0.12-0.02-98.61%-426.93%

Profit & Loss

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+15K786.02K6.7M15.13M12.84M14.39M16.19M5.2M72.05K
Revenue Growth %-51.4%7.53%1.26%-0.15%0.12%0.13%-0.68%-0.99%
Cost of Goods Sold+4.27K63.22K933.91K2.54M1.62M1.63M1.51M1.35M305.25K
COGS % of Revenue0.28%0.08%0.14%0.17%0.13%0.11%0.09%0.26%4.24%
Gross Profit+10.73K722.81K5.77M12.59M11.21M12.76M14.68M3.85M-233.2K
Gross Margin %0.72%0.92%0.86%0.83%0.87%0.89%0.91%0.74%-3.24%
Gross Profit Growth %-66.34%6.98%1.18%-0.11%0.14%0.15%-0.74%-1.06%
Operating Expenses+229.78K1.64M9.32M18.77M17.68M22.71M24.53M2.54M5.39M
OpEx % of Revenue15.32%2.08%1.39%1.24%1.38%1.58%1.52%0.49%74.81%
Selling, General & Admin229.78K1.57M8.67M17.22M16.38M21.06M22.9M1.47M2.82M
SG&A % of Revenue15.32%2%1.29%1.14%1.28%1.46%1.41%0.28%39.15%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses065.89K18.36K1.55M1.31M1.65M1.63M1.07M2.57M
Operating Income+-219.05K-915.07K-3.55M-6.19M-6.54M-9.95M-7.32M-2.94M-5.62M
Operating Margin %-14.6%-1.16%-0.53%-0.41%-0.51%-0.69%-0.45%-0.57%-78.05%
Operating Income Growth %--3.18%-2.88%-0.74%-0.06%-0.52%0.26%0.6%-0.91%
EBITDA+0-849.17K-2.9M-4.63M-4.81M-8.3M-5.7M-2.54M-5.48M
EBITDA Margin %--1.08%-0.43%-0.31%-0.38%-0.58%-0.35%-0.49%-76.11%
EBITDA Growth %---2.42%-0.6%-0.04%-0.72%0.31%0.55%-1.16%
D&A (Non-Cash Add-back)219.05K65.89K651.07K1.55M1.72M1.65M1.63M403.59K139.18K
EBIT-397.44K-889.38K-3.63M-6.05M-4.98M-10.04M-11.83M-6.35M-5.62M
Net Interest Income+4-12.33K-146.28K-889.9K-556.99K-501.22K6.69K-97.81K-674.51K
Interest Income414.82K7.54K7.79K6.07K2.88K9.84K27.16K3.47K
Interest Expense027.15K153.82K897.69K563.07K504.1K3.15K124.97K677.98K
Other Income/Expense-178.39K-1.47K-233.48K-765.96K993.86K-443.89K-4.51M-3.53M-674.51K
Pretax Income+-397.44K-916.53K-3.78M-6.95M-5.54M-10.54M-11.83M-6.48M-6.3M
Pretax Margin %-26.5%-1.17%-0.56%-0.46%-0.43%-0.73%-0.73%-1.25%-87.41%
Income Tax+000000000
Effective Tax Rate %0.96%0.06%0.81%1%1%1%1.55%1.45%1.44%
Net Income+-380.8K-57.18K-3.05M-6.95M-5.57M-10.54M-18.31M-9.42M-9.05M
Net Margin %-25.39%-0.07%-0.46%-0.46%-0.43%-0.73%-1.13%-1.81%-125.55%
Net Income Growth %-0.85%-52.4%-1.28%0.2%-0.89%-0.74%0.49%0.04%
Net Income (Continuing)-397.44K-916.53K-3.78M-6.95M-5.54M-10.54M-11.83M-6.48M-6.3M
Discontinued Operations000000-6.48M-1.71M-2.75M
Minority Interest283.36K-575.99K-1.63M-2.08M-2.62M0000
EPS (Diluted)+-2.56-0.38-12.65-28.55-15.11-14.02-19.43-7.36-7.76
EPS Growth %-0.85%-32.29%-1.26%0.47%0.07%-0.39%0.62%-0.05%
EPS (Basic)-2.56-0.38-12.65-28.55-15.11-14.02-19.43-5.82-7.76
Diluted Shares Outstanding149.02K150.4K241.43K258.45K368.34K751.72K942.46K1.11M1.57M
Basic Shares Outstanding149.02K150.4K241.43K258.45K368.34K751.72K942.46K1.62M1.57M
Dividend Payout Ratio---------

Balance Sheet

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+1.6M708.46K668.11K2.58M4.76M9.07M10.83M1.14M684.34K
Cash & Short-Term Investments876.21K127.79K194.32K373.69K2.62M7.12M763.21K221.51K504.19K
Cash Only876.21K127.79K194.32K373.69K2.62M7.12M763.21K221.51K504.19K
Short-Term Investments000000000
Accounts Receivable301K139.99K303.63K1.26M1.51M1.21M2.88M731.07K28.03K
Days Sales Outstanding7.32K6516.5430.3643.0530.6864.9751.34142
Inventory000312.26K0191.66K196.12K00
Days Inventory Outstanding---44.87-42.9647.46--
Other Current Assets2.74K93.04K170.16K633.3K619.73K547.54K6.99M191.54K152.12K
Total Non-Current Assets+0570.62K10.41M17.84M14.99M18.16M6.87M762K904.68K
Property, Plant & Equipment0542.79K3.33M7.41M5.59M7.27M5.21M762K904.68K
Fixed Asset Turnover-1.45x2.01x2.04x2.29x1.98x3.11x6.82x0.08x
Goodwill002.04M2.04M2.04M4.66M000
Intangible Assets004.26M7.17M6.61M5.8M1.37M00
Long-Term Investments000000000
Other Non-Current Assets027.83K773.48K1.22M743.31K430.87K300.43K00
Total Assets+1.6M1.28M11.07M20.42M19.75M27.23M11.08M1.14M1.59M
Asset Turnover0.01x0.61x0.61x0.74x0.65x0.53x1.46x4.54x0.05x
Asset Growth %--0.2%7.66%0.84%-0.03%0.38%-0.59%-0.9%0.39%
Total Current Liabilities+51.09K473.82K13.83M6.07M5.95M4.93M6.43M1.9M7.98M
Accounts Payable2.99K56.66K1.26M2.91M1.69M2.52M568.64K584.05K2.71M
Days Payables Outstanding255.91327.18493.07418.07380.35565.66137.6158.13.25K
Short-Term Debt0182.93K4.84M1.5M2.53M254.49K51.66K00
Deferred Revenue (Current)0130.91K454.38K189.69K295.07K320.92K241.67K00
Other Current Liabilities48.1K95.5K7.26M421.04K339.38K337.94K4.18M1.31M4.02M
Current Ratio31.35x1.50x0.05x0.42x0.80x1.84x1.68x0.60x0.09x
Quick Ratio31.35x1.50x0.05x0.37x0.80x1.80x1.65x0.60x0.09x
Cash Conversion Cycle----342.84--492.02-25.17--
Total Non-Current Liabilities+500K633.83K1.18M6.42M5.98M4.34M2.72M00
Long-Term Debt500K456.15K317.29K2.11M1.96M104.7K53.04K00
Capital Lease Obligations052.49K84.04K3.73M3.55M4.05M2.66M00
Deferred Tax Liabilities000000000
Other Non-Current Liabilities0125.18K774.45K578.87K468.76K189.38K000
Total Liabilities551.09K1.11M15.01M12.48M11.93M9.28M6.43M1.9M7.98M
Total Debt+500K759.83K5.26M8.38M9.14M5.9M4.16M00
Net Debt-376.2K632.04K5.06M8.01M6.51M-1.21M3.39M-221.51K-504.19K
Debt / Equity0.48x4.43x-1.06x1.17x0.33x0.89x--
Debt / EBITDA---------
Net Debt / EBITDA---------
Interest Coverage--33.70x-23.09x-6.89x-11.61x-19.74x-2323.58x-23.54x-8.29x
Total Equity+1.05M171.43K-3.93M7.94M7.81M17.95M4.65M-752.65K-6.39M
Equity Growth %--0.84%-23.94%3.02%-0.02%1.3%-0.74%-1.16%-7.5%
Book Value per Share7.051.14-16.2930.7121.2123.884.94-0.68-4.07
Total Shareholders' Equity767.1K747.42K-2.31M10.02M10.43M17.95M4.65M-752.65K-6.39M
Common Stock6.49K6.58K6.58K8.91K12.83K26.22K1.1K1.15K1.17K
Retained Earnings-433.9K-491.08K-3.54M-10.04M-15.05M-28.21M-46.52M-55.94M-64.98M
Treasury Stock000000000
Accumulated OCI000000000
Minority Interest283.36K-575.99K-1.63M-2.08M-2.62M0000

Cash Flow

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-880.59K-436.98K-1.81M-4.07M-5.99M-7.59M-10.29M-2.79M-3.16M
Operating CF Margin %-58.71%-0.56%-0.27%-0.27%-0.47%-0.53%-0.64%-0.54%-43.89%
Operating CF Growth %-0.5%-3.14%-1.25%-0.47%-0.27%-0.36%0.73%-0.13%
Net Income-380.8K-57.18K-3.05M-6.5M-5.54M-10.54M-11.83M-6.48M-6.3M
Depreciation & Amortization065.89K651.07K1.55M1.72M1.65M1.63M403.59K139.18K
Stock-Based Compensation0000000035.41K
Deferred Taxes000000000
Other Non-Cash Items-195.04K-780.99K-703.44K577.02K-857.87K975.75K2.48M2.47M-2.11M
Working Capital Changes-304.75K335.3K1.3M298.55K-1.32M326.35K-2.57M809.87K5.07M
Change in Receivables-305K208.42K-265.74K-412.81K-234.52K304.35K-1.75M1.45M-28.03K
Change in Inventory000000000
Change in Payables2.99K53.67K1.2M1.36M-1.26M281.43K-820.59K-388.47K5.06M
Cash from Investing+-243.21K-486.12K-1.6M-1.05M-569.74K-2.46M-259.98K-1.78M-375K
Capital Expenditures0-546.47K-1.58M-1.2M-369.74K-763.45K-331.38K00
CapEx % of Revenue-0.7%0.24%0.08%0.03%0.05%0.02%--
Acquisitions---------
Investments---------
Other Investing0000000-2.78M-375K
Cash from Financing+2M174.68K3.48M5.3M8.81M14.54M4.2M4.02M3.82M
Debt Issued (Net)---------
Equity Issued (Net)---------
Dividends Paid00000000-1.25M
Share Repurchases---------
Other Financing150K37.5K0000001.25M
Net Change in Cash---------
Free Cash Flow+-880.59K-983.45K-3.39M-5.27M-6.12M-8.29M-10.63M-2.79M-3.16M
FCF Margin %-58.71%-1.25%-0.51%-0.35%-0.48%-0.58%-0.66%-0.54%-43.89%
FCF Growth %--0.12%-2.45%-0.56%-0.16%-0.35%-0.28%0.74%-0.13%
FCF per Share-5.91-6.54-14.03-20.39-16.61-11.02-11.27-2.51-2.01
FCF Conversion (FCF/Net Income)2.31x7.64x0.59x0.59x1.08x0.72x0.56x0.30x0.35x
Interest Paid00097.15K00000
Taxes Paid00018.53K00000

Key Ratios

Metric201620172018201920202021202220232024
Return on Equity (ROE)-36.25%-9.36%--347.13%-70.69%-81.83%-162.03%-483.18%-
Return on Invested Capital (ROIC)--92.89%-275.4%-54.34%-32.39%-48.04%-44.33%-62.41%-
Gross Margin71.56%91.96%86.06%83.21%87.35%88.68%90.68%74.05%-323.66%
Net Margin-2538.65%-7.27%-45.57%-45.96%-43.37%-73.28%-113.14%-181.23%-12554.93%
Debt / Equity0.48x4.43x-1.06x1.17x0.33x0.89x--
Interest Coverage--33.70x-23.09x-6.89x-11.61x-19.74x-2323.58x-23.54x-8.29x
FCF Conversion2.31x7.64x0.59x0.59x1.08x0.72x0.56x0.30x0.35x
Revenue Growth-5140.17%752.53%125.73%-15.14%12.08%12.51%-67.89%-98.61%

Frequently Asked Questions

Growth & Financials

IMAC Holdings, Inc. (BACK) reported $0.0M in revenue for fiscal year 2024. This represents a 51% increase from $0.0M in 2016.

IMAC Holdings, Inc. (BACK) saw revenue decline by 98.6% over the past year.

IMAC Holdings, Inc. (BACK) reported a net loss of $9.7M for fiscal year 2024.

Dividend & Returns

Yes, IMAC Holdings, Inc. (BACK) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.

IMAC Holdings, Inc. (BACK) had negative free cash flow of $4.9M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.